MedTrace Logo

Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

NCT00224575 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2016-03-08

No results posted yet for this study

Summary

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Conditions

  • Myocardial Ischemia

Interventions

OTHER

diagnosis reassessment

Strategy of diagnosis reassessment following a decision tree.

OTHER

Diagnosis strategy and subsequent therapeutic reassessment

Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • legrain sylvie · APHP

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2005-11-30
Completion
2006-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00224575 on ClinicalTrials.gov